Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

RMD - RESMED INC


Close
232.33
-5.710   -2.458%

Share volume: 0
Last Updated: Tue 24 Dec 2024 06:00:41 PM CET
Surgical and Medical Instrument Manufacturing : 50.37%

PREVIOUS CLOSE
CHG
CHG%

$238.04
-5.71
-2.40%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
72%
Profitability 93%
Dept financing 28%
Liquidity 26%
Performance 74%
Company vs Stock growth
vs
Performance
5 Days
-1.98%
1 Month
-6.80%
3 Months
-3.39%
6 Months
26.51%
1 Year
35.69%
2 Year
11.65%
Key data
Stock price
$232.33
P/E Ratio 
35.26
DAY RANGE
$230.70 - $238.04
EPS 
$6.92
52 WEEK RANGE
$168.13 - $260.49
52 WEEK CHANGE
$34.45
MARKET CAP 
36.001 B
YIELD 
0.80%
SHARES OUTSTANDING 
146.932 M
DIVIDEND
$0.53
EX-DIVIDEND DATE
08/15/2024
NEXT EARNINGS DATE
10/24/2024
BETA 
1.02
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,067,653
AVERAGE 30 VOLUME 
$819,077
Company detail
CEO: Michael J. Farrell
Region: US
Website: resmed.com
Employees: 8,160
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company also provides AirView, a system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools.

Recent news